NES
OSIR

New England Securities’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

New England Securities’s Portfolio OSIR Stock Details OSIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$3K Hold
205
– – ﹤0.01% 1431
2014
Q3 		$3K Hold
205
– – ﹤0.01% 1458
2014
Q2 		$3K Hold
205
– – ﹤0.01% 1503
2014
Q1 		$3K Hold
205
– – ﹤0.01% 1471
2013
Q4 		$3K Buy
+205
New +$3.27K ﹤0.01% 1403

Other funds holding OSIR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

New England Securities's OSIR Position: Q4 2014 in Review

New England Securities held its Osiris Therapeutics, Inc. Common Stock (OSIR) position steady in Q4 2014 at 205 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #1431.

New England Securities first reported a position in OSIR in Q4 2013 and has held it in 5 quarters since. 66 funds tracked by Wall St. Rank hold OSIR as of Q4 2014.

  • New England Securities held 205 shares of Osiris Therapeutics, Inc. Common Stock worth $3K as of Q4 2014.
  • New England Securities left its Osiris Therapeutics, Inc. Common Stock share count unchanged in Q4 2014.
  • Osiris Therapeutics, Inc. Common Stock made up ﹤0.01% of New England Securities's portfolio in Q4 2014, its #1431 holding.
  • New England Securities first reported a position in Osiris Therapeutics, Inc. Common Stock in Q4 2013 and has held it in 5 quarters since.
  • 66 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q4 2014.

Based on New England Securities's 13F filing for Q4 2014, filed 26 Jan 2015.